
BioCardia BCDA
$ 1.27
0.0%
Quarterly report 2025-Q3
added 11-12-2025
BioCardia Depreciation & Amortization 2011-2025 | BCDA
Annual Depreciation & Amortization BioCardia
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 84 K | 82 K | 60 K | 68 K | 111 K | 88 K | 78 K | 39 K | 47 K | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 111 K | 39 K | 73 K |
Quarterly Depreciation & Amortization BioCardia
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 K | 5 K | 12 K | - | 16 K | 17 K | 19 K | - | 21 K | 21 K | 22 K | - | 29 K | 21 K | 16 K | - | 45 K | 30 K | 14 K | - | 52 K | 36 K | 22 K | - | 78 K | 49 K | 23 K | - | 66 K | 44 K | 22 K | - | 57 K | 36 K | 13 K | - | 30 K | 21 K | 10 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 78 K | 4 K | 28.4 K |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
1.4 M | $ 4.79 | 2.35 % | $ 795 M | ||
|
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | ||
|
Aclaris Therapeutics
ACRS
|
807 K | $ 3.04 | 4.83 % | $ 235 M | ||
|
Alpine Immune Sciences
ALPN
|
597 K | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
398 K | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | ||
|
Aptevo Therapeutics
APVO
|
352 K | $ 0.93 | -8.81 % | $ 257 K | ||
|
Athersys
ATHX
|
1.43 M | - | 3.77 % | $ 22.4 M | ||
|
AVROBIO
AVRO
|
617 K | - | 1083.1 % | $ 745 M | ||
|
BioDelivery Sciences International
BDSI
|
140 K | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
172 M | - | 0.49 % | $ 251 B | ||
|
BioVie
BIVI
|
229 K | $ 1.27 | -3.05 % | $ 1.88 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
11 K | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
9 M | - | -7.31 % | $ 87 M | ||
|
bluebird bio
BLUE
|
28 M | - | - | $ 546 M | ||
|
Calithera Biosciences
CALA
|
300 K | - | -10.95 % | $ 876 K | ||
|
Catalyst Biosciences
CBIO
|
1.07 M | $ 12.37 | 2.06 % | $ 814 M | ||
|
Cerevel Therapeutics Holdings
CERE
|
5.63 M | - | - | $ 7.29 B | ||
|
ARCA biopharma
ABIO
|
27 K | - | 1052.0 % | $ 415 M | ||
|
Celldex Therapeutics
CLDX
|
3.18 M | $ 26.83 | 0.94 % | $ 1.73 M | ||
|
Acasti Pharma
ACST
|
7 K | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
9.45 M | - | -15.15 % | $ 60.3 M | ||
|
Celsion Corporation
CLSN
|
240 K | - | -6.63 % | $ 13.9 M | ||
|
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.2 M | $ 26.81 | 1.36 % | $ 1.3 B | ||
|
Corcept Therapeutics Incorporated
CORT
|
795 K | $ 83.59 | 1.95 % | $ 8.63 B | ||
|
Anika Therapeutics
ANIK
|
6.43 M | $ 9.48 | 0.96 % | $ 139 M | ||
|
CorMedix
CRMD
|
70.8 K | $ 12.19 | 1.75 % | $ 621 M | ||
|
Cortexyme
CRTX
|
322 K | - | -1.05 % | $ 67.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
14 K | $ 0.18 | -25.03 % | $ 392 M | ||
|
CTI BioPharma Corp.
CTIC
|
1.95 M | - | - | $ 1.2 B | ||
|
Arena Pharmaceuticals
ARNA
|
3.87 M | - | -6.81 % | $ 3.04 B | ||
|
Acer Therapeutics
ACER
|
66 K | - | 2.71 % | $ 14 M | ||
|
Axon Enterprise
AXON
|
48.4 M | $ 591.15 | 0.02 % | $ 44.8 B | ||
|
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
5.38 M | $ 2.53 | -0.39 % | $ 15.9 M | ||
|
Acorda Therapeutics
ACOR
|
31.7 M | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
41 K | - | -5.38 % | $ 6.06 M |